A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
Clinical trial NCT03701334 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03701334
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-07
- Primary completion
- 2030-05-29
- Enrollment
- 5101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.